davidmcnam Profile Banner
David McNamara Profile
David McNamara

@davidmcnam

Followers
343
Following
2K
Media
11
Statuses
918

Advanced Imaging at @SpectrumHealth @michiganstateu | University of Michigan, Northwestern (x2), and UTSW Alumnus | #imaging #interventionalimaging #LAmyopathy

Grand Rapids, Michigan
Joined February 2018
Don't wanna be here? Send us removal request.
@PrashSanders
Prash Sanders
15 days
Strong work by the exercise physiology team of #CHRD @UniofAdelaide
@hrs_journal
HeartRhythm
15 days
The Association of Age and Left Atrial Dysfunction in Patients with Atrial Fibrillation @Elliott_AD @JacksonHowie14 @PrashSanders https://t.co/BepASGRf5G
0
6
21
@DrDiGiorgio
Anthony DiGiorgio, DO, MHA
17 days
Excellent read: “Epic was never built to ingest or learn from this scale of data. It was built to satisfy billing requirements, regulatory checklists, and documentation workflows. That is the beginning and end of its architecture. It is not a learning system, much less an AI
@jclatorre
Julio La Torre, MD
17 days
I recently took @tszzl and @RichardHanania (true story lolz-and both advisors to my new venture in full disclosure) to one of the countries largest academic medical centers. @tszzl has since wrote a viral X thread thats worth reading again https://t.co/8kKnSDObh2 It speaks for
48
74
601
@kaulcsmc
Sanjay Kaul
1 month
1/ OCEAN trial of Rivaroxaban vs ASA 1yr post-A fib ablation CHA2DS2-VASc score: 2.2, h/o stroke 2.7% Expected PEP annual rates in DOAC and ASA arm: 2.1% vs 3.5% Sample size: beta 0.2, alpha 0.05, delta RR 0.6 (? too optimistic) Sample size: 1572 https://t.co/A0UFvemybI
Tweet card summary image
nejm.org
Whether successful catheter ablation for atrial fibrillation eliminates the need for long-term oral anticoagulant therapy is unknown. We conducted an international, open-label, randomized, blinded-...
1
14
39
@DrDamluji
Abdulla A. Damluji, MD, PhD
1 month
Evolocumab in Patients without a Previous Myocardial Infarction or Stroke: @NEJM @AHAScience #AHA25 🥸VESALIUS-CV - subtilisin–kexin type 9 (PCSK9) inhibitor evolocumab 😱Summary 👇👇👇
3
59
229
@NEJM
NEJM
1 month
Presented at #AHA25: In patients with atrial fibrillation and a drug-eluting stent placed at least 1 year earlier, monotherapy with a non–vitamin K antagonist oral anticoagulant was noninferior to combination therapy with clopidogrel for net adverse clinical events. Full ADAPT
0
118
280
@ehj_ed
EHJ Editor-in-Chief
2 months
Genetic testing in early-onset atrial fibrillation uncovers a high rate of pathogenic variants and changes clinical care. Read more in #EHJ. https://t.co/GSXwUGbc7E #PrecisionCardiology #cardiotwitter @ESC_Journals @escardio
2
40
107
@gracybarros
gracielly barros
2 months
Mitral valve with localized degenerative disease (P2 flail), preserved and symmetric annular geometry, showing a primary mechanism of mitral regurgitation (Carpentier type II). Volumetric reconstruction with precise anatomical mapping for valve repair planning.#echofirst #philips
1
13
56
@davidmcnam
David McNamara
2 months
Excited to share our institution's efforts towards developing a mature heart team in @SCAI led by star fellow Dr. Akram. Designing and Implementing a Heart Team: Institutional Experiences Over the Past 10 Years
Tweet card summary image
jscai.org
The heart team (HT) is a multidisciplinary team that performs a comprehensive review of patients with complex cardiac issues, collaborates on potential treatment options, and provides the patient...
0
1
3
@davidmcnam
David McNamara
3 months
Excellent work led by @IbrahimMKhaleel demonstrating how masses on the left atrial ridge may complicate LAAO in @CASEfromASE : https://t.co/PjfUsSuJG4 @CASivaram1
0
0
1
@davidmcnam
David McNamara
3 months
Great to see momentum in this space. Important to consider proper shielding mechanisms. Keep up the great work @PWesslyMD !
@CASivaram1
Chittur Sivaram MD MACP MACC
4 months
#ASE2025 ✅ What did I learn today at ASE2025? ✅ @PWesslyMD and colleagues found very low risk of pelvic radiation to interventional echocardiographers with proper shielding @renujain19 @davidmcnam @DavidWienerMD @TWeickert78 @iamritu @NadeenFaza @EGarciaSayan
1
2
8
@StephaneLeung
Stephane Leung, MD MSc FRCSC
3 months
10 year old ViV TAVR (CEV inside a 23mm magna placed in 2011, TAVR in 2015). Calcified leaflet led to complete tearing of the cusp from the frame. #TAVR #ViVtavr #cardiacsurgery #Medtronic #corevalve
3
4
20
@CASivaram1
Chittur Sivaram MD MACP MACC
4 months
✅ The good old stethoscope 🩺 might be making a comeback in VHD aided this time by AI for respectability! ✅ Another example of back to the future @dr_benoy_n_shah @ppsengupta1 @VicFerrariMD @DavidWienerMD @DrRajeshG1 @Hragy @iamritu @HeartOTXHeartMD
7
25
94
@alex1708ander
Alexander Mladenow MD
4 months
#echofirst detection of LAA thrombus can be very challenging…even in TEE 👉 I usually use multiplane imaging, looking at LAA in different planes 👀 A 🇩🇪 expert proposal⬇️ https://t.co/JBDASNsa5a 👉 intraop TEE case example
@sudarshanballa
Sudarshan Balla
4 months
Question for #echofirst folks. I have not seen this before. TEE performed prior to cardioversion. LAA before and after UEA. Why are post UEA images without a filling defect? If someone can educate me on why this is the case here? @WvuCvFellows @CASivaram1 @argulian @iamritu
1
8
26
@CASivaram1
Chittur Sivaram MD MACP MACC
5 months
#echofirst ✅ Incremental value of transillumination (TI) rendered 3D ✅ MR due to indentation/cleft at P2P3 ⬇️. Regurg location not seen well on 3D (image 1) ✅ TI images (2 & 3) show regurg orifice better ✅ Image 4 clearly localizes MR to cleft/indentation ✅ Cool shadow of
6
13
54
@josecaferca
Jose Carlos Fernández Camacho
6 months
9y MV biological prosthesis in 83yo 👵. What a “mitral week”! No clinical suspicion of infection @alex1708ander @alexsfelixecho @cardiojsl @NMerke @DrRajeshG1 @RevistaRetic @JovenesSec @elenadiaz @elenadpelaez @fiore_corrado @purviparwani @iamritu @argulian @jose_lezo
8
21
57
@CMichaelGibson
C. Michael Gibson MD
6 months
Dr. Rohan Khera and I discuss: Artificial Intelligence in cardiovascular care. S/b BridgeBio Pharma, Inc. https://t.co/m0Q8GPHvIB
0
11
34
@NMerke
Nicolas Merke
6 months
@FGraziani_Grace @mohamed_elsabah @KFAFHCards @iamritu @hahn_rt @JaeKOh2 @EchoSoliman @ASE360 @CASivaram1 @EACVIPresident Always LVOT SV - RVOT SV and if AR is isolated LV SV - RV SV, DA holodiastolic reflow, linear LV dimensions. PHT IMO not always possible
1
2
10
@iamritu
Ritu Thamman MD
2 years
5 Abnormal septum motion patterns on #echofirst that are nonischemic @BijoyKhandheria https://t.co/Ne5kpoJadB 1.LBBB septal flash-apical rocking 🔺LV apex moves t/w RV due to early septal shortening & posterolateral stretch 🔺delayed posterolateral contraction leads to
0
103
249
@drbennisahmed
Ahmed Bennis MD 🫀
7 months
Carvedilol as Single Therapy for Heart Failure With Improved Ejection Fraction: A CATHEDRAL-HF Withdrawal of HF treatment maintaining carvedilol vs usual treatment led to similar rates of worsening of left ventricular function at 52 weeks https://t.co/wkHHI8wVjK
0
27
88